454 related articles for article (PubMed ID: 30796549)
1. Clinical predictors of survival in metastatic uveal melanoma.
Lorenzo D; Piulats JM; Ochoa M; Arias L; Gutiérrez C; Català J; Cobos E; Garcia-Bru P; Dias B; Padrón-Pérez N; Caminal JM
Jpn J Ophthalmol; 2019 Mar; 63(2):197-209. PubMed ID: 30796549
[TBL] [Abstract][Full Text] [Related]
2. Treatment of uveal melanoma metastatic to the liver: a review of the M. D. Anderson Cancer Center experience and prognostic factors.
Bedikian AY; Legha SS; Mavligit G; Carrasco CH; Khorana S; Plager C; Papadopoulos N; Benjamin RS
Cancer; 1995 Nov; 76(9):1665-70. PubMed ID: 8635073
[TBL] [Abstract][Full Text] [Related]
3. A prognostic model and staging for metastatic uveal melanoma.
Eskelin S; Pyrhönen S; Hahka-Kemppinen M; Tuomaala S; Kivelä T
Cancer; 2003 Jan; 97(2):465-75. PubMed ID: 12518371
[TBL] [Abstract][Full Text] [Related]
4. Local Recurrence Significantly Increases the Risk of Metastatic Uveal Melanoma.
Ophthalmic Oncology Task Force
Ophthalmology; 2016 Jan; 123(1):86-91. PubMed ID: 26505803
[TBL] [Abstract][Full Text] [Related]
5. Hepatic Ultrasonography for Surveillance in Patients With Uveal Melanoma.
Choudhary MM; Gupta A; Bena J; Emch T; Singh AD
JAMA Ophthalmol; 2016 Feb; 134(2):174-80. PubMed ID: 26633182
[TBL] [Abstract][Full Text] [Related]
6. Sex Disparity in Survival of Patients With Uveal Melanoma: Better Survival Rates in Women Than in Men in South Korea.
Park SJ; Oh CM; Yeon B; Cho H; Park KH
Invest Ophthalmol Vis Sci; 2017 Mar; 58(3):1909-1915. PubMed ID: 28362882
[TBL] [Abstract][Full Text] [Related]
7. Variates of survival in metastatic uveal melanoma.
Rietschel P; Panageas KS; Hanlon C; Patel A; Abramson DH; Chapman PB
J Clin Oncol; 2005 Nov; 23(31):8076-80. PubMed ID: 16258106
[TBL] [Abstract][Full Text] [Related]
8. Long-Term Metastatic Risk after Biopsy of Posterior Uveal Melanoma.
Bagger M; Smidt-Nielsen I; Andersen MK; Jensen PK; Heegaard S; Andersen KK; Friis S; Kiilgaard JF
Ophthalmology; 2018 Dec; 125(12):1969-1976. PubMed ID: 29705056
[TBL] [Abstract][Full Text] [Related]
9. Survival in patients with presymptomatic diagnosis of metastatic uveal melanoma.
Kim IK; Lane AM; Gragoudas ES
Arch Ophthalmol; 2010 Jul; 128(7):871-5. PubMed ID: 20625048
[TBL] [Abstract][Full Text] [Related]
10. Uveal Metastasis: Clinical Features and Survival Outcome of 2214 Tumors in 1111 Patients Based on Primary Tumor Origin.
Shields CL; Welch RJ; Malik K; Acaba-Berrocal LA; Selzer EB; Newman JH; Mayro EL; Constantinescu AB; Spencer MA; McGarrey MP; Knapp AN; Graf AE; Altman AJ; Considine SP; Shields JA
Middle East Afr J Ophthalmol; 2018; 25(2):81-90. PubMed ID: 30122853
[TBL] [Abstract][Full Text] [Related]
11. Delayed systemic recurrence of uveal melanoma.
Kolandjian NA; Wei C; Patel SP; Richard JL; Dett T; Papadopoulos NE; Bedikian AY
Am J Clin Oncol; 2013 Oct; 36(5):443-9. PubMed ID: 22706174
[TBL] [Abstract][Full Text] [Related]
12. Clinicopathological Characteristics and Prognosis for Survival after Enucleation of Uveal Melanoma in Chinese Patients: Long-term Follow-up.
Yue H; Qian J; Yuan Y; Zhang R; Bi Y; Meng F; Xuan Y
Curr Eye Res; 2017 May; 42(5):759-765. PubMed ID: 27911584
[TBL] [Abstract][Full Text] [Related]
13. Prognostic factors of liver metastases from uveal melanoma.
Kodjikian L; Grange JD; Baldo S; Baillif S; Garweg JG; Rivoire M
Graefes Arch Clin Exp Ophthalmol; 2005 Oct; 243(10):985-93. PubMed ID: 15891893
[TBL] [Abstract][Full Text] [Related]
14. Prognosis of Mucosal, Uveal, Acral, Nonacral Cutaneous, and Unknown Primary Melanoma From the Time of First Metastasis.
Kuk D; Shoushtari AN; Barker CA; Panageas KS; Munhoz RR; Momtaz P; Ariyan CE; Brady MS; Coit DG; Bogatch K; Callahan MK; Wolchok JD; Carvajal RD; Postow MA
Oncologist; 2016 Jul; 21(7):848-54. PubMed ID: 27286787
[TBL] [Abstract][Full Text] [Related]
15. Clinical Features, Metastasis, and Survival in Patients Younger Than 21 Years With Posterior Uveal Melanoma.
Fry MV; Augsburger JJ; Corrêa ZM
JAMA Ophthalmol; 2019 Jan; 137(1):75-81. PubMed ID: 30422230
[TBL] [Abstract][Full Text] [Related]
16. Prognostic factors for survival in patients with mucosal and ocular melanoma treated with ipilimumab: Turkish Oncology Group study.
Arzu Yaşar H; Turna H; Esin E; Murat Sedef A; Alkan A; Oksuzoglu B; Ozdemir N; Sendur MN; Sezer A; Kılıckap S; Utkan G; Akbulut H; Celik I; Abalı H; Urun Y
J Oncol Pharm Pract; 2020 Mar; 26(2):267-272. PubMed ID: 30924738
[TBL] [Abstract][Full Text] [Related]
17. The prognostic effect of American Joint Committee on Cancer staging and genetic status in patients with choroidal and ciliary body melanoma.
Bagger M; Andersen MT; Andersen KK; Heegaard S; Andersen MK; Kiilgaard JF
Invest Ophthalmol Vis Sci; 2014 Dec; 56(1):438-44. PubMed ID: 25537201
[TBL] [Abstract][Full Text] [Related]
18. [Prognostic factors for uveal melanoma].
Amiryan AG; Saakyan SV
Vestn Oftalmol; 2015; 131(1):90-95. PubMed ID: 25872392
[TBL] [Abstract][Full Text] [Related]
19. Prospective study of surveillance testing for metastasis in 100 high-risk uveal melanoma patients.
Piperno-Neumann S; Servois V; Mariani P; Plancher C; Lévy-Gabriel C; Lumbroso-Le Rouic L; Couturier J; Asselain B; Desjardins L; Cassoux N
J Fr Ophtalmol; 2015 Jun; 38(6):526-34. PubMed ID: 25978872
[TBL] [Abstract][Full Text] [Related]
20. Independent Prognostic Significance of Gene Expression Profile Class and Largest Basal Diameter of Posterior Uveal Melanomas.
Corrêa ZM; Augsburger JJ
Am J Ophthalmol; 2016 Feb; 162():20-27.e1. PubMed ID: 26596399
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
